0.00 - 0.01
0.00 - 0.02
289 / 496.9K (Avg.)
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.00%
FCF growth of 0.00% while LBL.AX is zero. Bruce Berkowitz would see if modest improvements in free cash can accelerate further.
-82.85%
Negative 10Y revenue/share CAGR while LBL.AX stands at 314.05%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-77.92%
Negative 5Y CAGR while LBL.AX stands at 73.29%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-51.81%
Negative 3Y CAGR while LBL.AX stands at 24.23%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
134.55%
OCF/share CAGR of 134.55% while LBL.AX is zero. Bruce Berkowitz might see a slight advantage that could compound over time.
-55.52%
Negative 5Y OCF/share CAGR while LBL.AX is at 0.00%. Joel Greenblatt would question the firm’s operational model or cost structure.
333.64%
3Y OCF/share CAGR of 333.64% while LBL.AX is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
No Data
No Data available this quarter, please select a different quarter.
73.19%
Below 50% of LBL.AX's 228.91%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-390.88%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
16.04%
R&D growth of 16.04% while LBL.AX is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
No Data
No Data available this quarter, please select a different quarter.